Table 4 |
|||||
| The numbers and percentages of polymorphous low-grade adenocarcinomas in malignant minor salivary gland tumors by continent as described in the studies included in this review as described in the studies included in this review | |||||
| Continent | MMSGTs | PLGA | PLGA/MMSGTs | ||
| n | % | n | % | % | |
| Africa | 178 | 2.6% | 14 | 3.2% | 7.9% |
| America | 1,668 | 24.2% | 115 | 26.7% | 6.9% |
| Asia | 3,702 | 53.7% | 144 | 33.4% | 3.9% |
| Europe | 1,313 | 19.1% | 152 | 35.3% | 11.6% |
| Oceania | 30 | 0.4% | 6 | 1.4% | 20.0% |
| Total | 6,891 | 100.0 | 431 | 100.0 | 6.3 |
MMSGTs: malignant minor salivary gland tumors; PLGA: polymorphous low-grade adenocarcinoma.
de Araujo et al. Diagnostic Pathology 2013 8:6 doi:10.1186/1746-1596-8-6
